Showing results (31-40 of 188) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004
Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancerAtsushi Osoegawa, Ichiro Yoshino, Shinji Tanaka, et al.
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia|August 21, 2015
Prognostic Factors for Survival after Resection of Pulmonary Metastases from Colorectal CarcinomaAtsushi Osoegawa, Takuro Kometani, Seiichi Fukuyama, et al.
Anticancer Research|August 19, 2007
A new mechanism for primary resistance to gefitinib in lung adenocarcinoma: the role of a novel G796A mutation in exon 20 of EGFRHidetaka Uramoto, Takeshi Uchiumi, Hiroto Izumi, et al.
Chest|July 13, 2002
Establishment of 15 cancer cell lines from patients with lung cancer and the potential tools for immunotherapyMasakazu Sugaya, Mitsuhiro Takenoyama, Toshihiro Osaki, et al.
Scientific Reports|March 1, 2019
Elevated red cell distribution width to platelet count ratio predicts poor prognosis in patients with breast cancerHideya Takeuchi, Miyuki Abe, Yohei Takumi, et al.
Molecular Medicine Reports|April 9, 2011
Reduced expression of catenin subtypes is a potential indicator of unfavorable prognosis in esophageal squamous cell carcinomaTadahiro Nozoe, Tsunehiro Oyama, Hidetaka Uramoto, et al.
Lung Cancer (Amsterdam, Netherlands)|July 11, 2009
Acquired resistance to gefitinib: the contribution of mechanisms other than the T790M, MET, and HGF statusTakamitsu Onitsuka, Hidetaka Uramoto, Naohiro Nose, et al.
Surgery|February 1, 2002
Micrometastasis in the bone marrow of patients with lung cancer associated with a reduced expression of E-cadherin and beta-catenin: risk assessment by immunohistochemistryKenji Sugio, Shinichiro Kase, Takashi Sakada, et al.
Anticancer Research|July 5, 2020
Evaluating the Platelet Distribution Width-to-Plateletcrit Ratio as a Prognostic Marker for Patients With Breast CancerHideya Takeuchi, Daiki Noda, Miyuki Abe, et al.
Thoracic Cancer|July 17, 2023
Significance of programmed death-ligand 1 expression in resected lung cancer and its relationship with EGFR mutationAtsushi Osoegawa, Miyuki Abe, Yohei Takumi, et al.
Pageof 19